Selling to the Energy Sector
The Energy sector operates on reliability and price volatility, where even a small drop in efficiency can erase millions in profit. To win these deals, your sales team must move beyond 'hardware specs' to prove they are optimizing resource extraction and reducing maintenance gaps.
Upstream Oil & Gas Highlights
- The upstream oil and gas sector focuses on exploration and production (E&P), generating revenue by extracting crude oil and natural gas, with prices driven by global supply and demand.
- Profits in this industry depend on the gap between the average realized price per barrel of oil equivalent (BOE) and the cost of exploration and production. The upstream sector experiences the largest profit swings, thriving when commodity prices are high but facing significant challenges during price downturns. Margins can swing from year to year, and even quarter to quarter.
- This asset-intensive industry relies heavily on advanced technologies, including seismic imaging, unconventional drilling, and innovation, to enhance efficiency and reduce costs.
- Cash flow is highly sensitive to commodity price volatility, with high prices driving reinvestment into exploration, reserves development, and maintaining financial stability during downturns.
- Other key measures upstream oil and gas companies track include average realized price, lifting costs, reserve replacement ratio, and employee safety measures like total recordable incident rate or lost time injury frequency.
Compare your client's results to industry and S&P 500 results.
|
Upstream |
S&P 500 |
|
|
CASH |
||
|
Cash and Cash Equivalents as a % of Sales |
16.2% |
22.7% |
|
Cash Generated from Operations as a % of Sales |
46.3% |
20.9% |
|
|
||
|
Gross Profit Margin % |
51.4% |
49.6% |
|
Operating Profit Margin % |
25.9% |
23.2% |
|
Net Profit Margin % |
12.1% |
12.9% |
|
|
||
|
Return on Assets (ROA) % |
7.5% |
8.4% |
|
Equity Ratio |
43.5% |
33.7% |
|
|
||
|
Revenue Growth Rate % |
10.2% |
6.3% |
|
Net Income Growth Rate % |
23.8% |
8.1% |
|
|
||
|
Revenue per Employee |
$0.8M |
$1.6M |
Notes:
-
Because cash amounts can vary dramatically from company to company based on a company’s overall “size,” we’ve presented the numbers as a percentage of sales or revenue: the cash metric divided by total revenue or sales and then multiplied by 100.
-
S&P 500 averages are calculated based on 3 years of annual reports as of July 2024, rounded. However, because certain financial industries, like asset management companies and diversified banks, hold large amounts of cash, they have been removed from the cash calculations.
-
Most industry or sector averages are also calculated based on 3 years of annual reports from S&P 500 companies. However, certain companies or subsectors in the S&P sometimes skew the data far from what is typical for an industry, so we have occasionally removed some companies or subsectors or changed periods in our calculations to provide a more accurate set of comparison data.
What are Health Insurance CEOs telling Wall Street right now? We analyzed the latest annual reports from five top players to identify the mission-critical priorities shaping their 2026 spending.
1. Profitability and LTV Over Raw Growth:
The era of growth at all costs is over. Insurers are intentionally shedding unprofitable members and exiting certain geographies to protect their bottom lines. Humana has explicitly shifted its strategy away from "loss leader plans," focusing instead on maximizing customer lifetime value (LTV) and retaining high-quality membership. Commercial growth is similarly measured, with companies like Elevance and UnitedHealth prioritizing margin integrity over raw volume.
2. Massive AI and Automation Initiatives:
Artificial intelligence is being aggressively deployed to counter rising administrative and medical costs. UnitedHealth Group anticipates nearly $1 billion in AI-enabled operating cost reductions in 2026 alone, using it to handle over 80% of member calls and streamline advocacy. Elevance is also making targeted investments to embed AI-enabled capabilities that simplify the member experience and speed up prior authorizations.
3. Hyper-Focus on Specific High-Cost Trends:
Rather than fighting general medical inflation, insurers are targeting specific spikes in utilization. Centene noted that behavioral health is driving roughly 50% of their excess medical trend, with home health and high-cost specialty drugs acting as secondary pressure points. Solutions that can effectively manage complex populations or utilize advanced algorithms to detect fraud, waste, and abuse in these areas are highly attractive.
4. Pharmacy Benefit Transformation: The pharmacy benefit manager (PBM) space is undergoing a massive structural shift. Cigna and UnitedHealth are heavily promoting new, transparent, "rebate-free" pricing models that pass savings directly to clients and consumers. Furthermore, insurers are heavily leaning into the adoption of lower-cost biosimilars to generate billions in savings over the next few years.
The Scenario:
A SaaS vendor selling an AI-driven claims tool was struggling to overcome the "we already have a large internal team for this" objection from a C-suite executive at a mid-sized health insurer.
The Strategy:
Instead of focusing on software features, the rep used the Revenue per Employee metric ($8.9M industry average). They proved that while the insurer’s revenue was growing, their headcount was growing faster—dropping their specific ratio to $7.2M (underperforming the industry).
The Pivot:
"Your business model requires high leverage; every employee needs to support nearly $9M in revenue just to protect your 3.3% net margin. Currently, your claims team spends 40% of their time on manual entry. We aren't here to replace your team; we are here to get your Revenue per Employee back above the $8.9M benchmark by automating 'low-value' touches."
The Result:
The executive shifted from seeing a "software cost" to a "margin protector." The deal closed because the vendor aligned with the executive’s hyper-focus on operational efficiency and headcount leverage.
The Scenario:
A workplace consultant was pitching a space-utilization audit to a COO facing a "return to office" dilemma. The COO was considering a generic mandate to bring everyone back just to justify lease costs, despite the risk to retention.
The Strategy:
The consultant ignored aesthetics and focused on the 3.3% Net Profit Margin. They analyzed the insurer's footprint and found three regional centers were only 40% occupied, creating a massive "administrative leakage" that was eroding the bottom line.
The Pivot:
"Your real estate overhead is a significant drag on your 3.3% margin. By rightsizing your footprint through activity-based zones, we can exit 30,000 sq. ft. of space, saving $1.2M in annual OpEx. To generate that same $1.2M in profit via new business, your sales team would have to close $36M in new premiums. We can give you that result today without a single new sale."
The Result:
The COO realized the audit wasn't a design project—it was a capital allocation strategy. They greenlit the study because the cost was negligible compared to the $36M in "equivalent premium growth" it uncovered.
- Profitability and LTV Over Raw Growth: The era of growth at all costs is over. Insurers are intentionally shedding unprofitable members and exiting certain geographies to protect their bottom lines. Humana has explicitly shifted its strategy away from "loss leader plans," focusing instead on maximizing customer lifetime value (LTV) and retaining high-quality membership. Commercial growth is similarly measured, with companies like Elevance and UnitedHealth prioritizing margin integrity over raw volume.
- Massive AI and Automation Initiatives: Artificial intelligence is being aggressively deployed to counter rising administrative and medical costs. UnitedHealth Group anticipates nearly $1 billion in AI-enabled operating cost reductions in 2026 alone, using it to handle over 80% of member calls and streamline advocacy. Elevance is also making targeted investments to embed AI-enabled capabilities that simplify the member experience and speed up prior authorizations.
- Hyper-Focus on Specific High-Cost Trends: Rather than fighting general medical inflation, insurers are targeting specific spikes in utilization. Centene noted that behavioral health is driving roughly 50% of their excess medical trend, with home health and high-cost specialty drugs acting as secondary pressure points. Solutions that can effectively manage complex populations or utilize advanced algorithms to detect fraud, waste, and abuse in these areas are highly attractive.
- Pharmacy Benefit Transformation: The pharmacy benefit manager (PBM) space is undergoing a massive structural shift. Cigna and UnitedHealth are heavily promoting new, transparent, "rebate-free" pricing models that pass savings directly to clients and consumers. Furthermore, insurers are heavily leaning into the adoption of lower-cost biosimilars to generate billions in savings over the next few years.
Midstream Oil & Gas Highlights
- The midstream sector handles the gathering, processing, storing, and transporting of crude oil and natural gas, earning revenue through fee-based contracts that provide stable cash flow.
- Many midstream companies operate as master limited partnerships (MLPs), offering tax benefits and distributing a large portion of cash flow to investors.
- While cash flow is stable, significant reinvestment in infrastructure is required to support demand growth and maintain capacity.
- Profits depend on operational efficiency and throughput volume, supported by extensive pipeline networks, storage facilities, and processing infrastructure. Revenue and profit growth rates can vary significantly, based on demand shifts.
- Key metrics include throughput volume, pipeline utilization, and capital expenditures on infrastructure.
Compare your client's results to industry and S&P 500 results.
|
Midstream Industry Average |
S&P 500 |
|
|
CASH |
||
|
Cash and Cash Equivalents as a % of Sales |
6.1% |
22.7% |
|
Cash Generated from Operations as a % of Sales |
45.6% |
20.9% |
|
|
||
|
Gross Profit Margin % |
50.1% |
49.6% |
|
Operating Profit Margin % |
27.5% |
23.2% |
|
Net Profit Margin % |
13.3% |
12.9% |
|
|
||
|
Return on Assets (ROA) % |
3.17% |
8.4% |
|
Equity Ratio |
34.9% |
33.7% |
|
|
||
|
Revenue Growth Rate % |
5.7% |
6.3% |
|
Net Income Growth Rate % |
4.2% |
8.1% |
|
|
||
|
Revenue per Employee |
$0.8M |
$1.6M |
Notes:
-
Because cash amounts can vary dramatically from company to company based on a company’s overall “size,” we’ve presented the numbers as a percentage of sales or revenue: the cash metric divided by total revenue or sales and then multiplied by 100.
-
S&P 500 averages are calculated based on 3 years of annual reports as of July 2024, rounded. However, because certain financial industries, like asset management companies and diversified banks, hold large amounts of cash, they have been removed from the cash calculations.
-
Most industry or sector averages are also calculated based on 3 years of annual reports from S&P 500 companies. However, certain companies or subsectors in the S&P sometimes skew the data far from what is typical for an industry, so we have occasionally removed some companies or subsectors or changed periods in our calculations to provide a more accurate set of comparison data.
- Profitability and LTV Over Raw Growth: The era of growth at all costs is over. Insurers are intentionally shedding unprofitable members and exiting certain geographies to protect their bottom lines. Humana has explicitly shifted its strategy away from "loss leader plans," focusing instead on maximizing customer lifetime value (LTV) and retaining high-quality membership. Commercial growth is similarly measured, with companies like Elevance and UnitedHealth prioritizing margin integrity over raw volume.
- Massive AI and Automation Initiatives: Artificial intelligence is being aggressively deployed to counter rising administrative and medical costs. UnitedHealth Group anticipates nearly $1 billion in AI-enabled operating cost reductions in 2026 alone, using it to handle over 80% of member calls and streamline advocacy. Elevance is also making targeted investments to embed AI-enabled capabilities that simplify the member experience and speed up prior authorizations.
- Hyper-Focus on Specific High-Cost Trends: Rather than fighting general medical inflation, insurers are targeting specific spikes in utilization. Centene noted that behavioral health is driving roughly 50% of their excess medical trend, with home health and high-cost specialty drugs acting as secondary pressure points. Solutions that can effectively manage complex populations or utilize advanced algorithms to detect fraud, waste, and abuse in these areas are highly attractive.
- Pharmacy Benefit Transformation: The pharmacy benefit manager (PBM) space is undergoing a massive structural shift. Cigna and UnitedHealth are heavily promoting new, transparent, "rebate-free" pricing models that pass savings directly to clients and consumers. Furthermore, insurers are heavily leaning into the adoption of lower-cost biosimilars to generate billions in savings over the next few years.
Downstream Oil & Gas Highlights
- Profits depend on the crack spread, which is the difference between the cost of crude oil and the price of refined products. Margins are generally thinner than in the upstream or midstream segments.
- This asset-intensive industry relies on refining facilities, distribution networks, and retail operations, emphasizing efficiency and cost control to improve profitability.
- Cash flow is steady but is reinvested in maintenance, modernization, and compliance with environmental regulations and capital expenditures to upgrade facilities and improve efficiency.
- Key metrics include gross refining margin, refinery utilization rate, and employee safety metrics like total recordable incident rate.
Compare your client's results to industry and S&P 500 results.
|
Downstream |
S&P 500 |
|
|
CASH |
||
|
Cash and Cash Equivalents as a % of Sales |
3.6% |
22.7% |
|
Cash Generated from Operations as a % of Sales |
4.7% |
20.9% |
|
|
||
|
Gross Profit Margin % |
6.5% |
49.6% |
|
Operating Profit Margin % |
3.1% |
23.2% |
|
Net Profit Margin % |
2.5% |
12.9% |
|
|
||
|
Return on Assets (ROA) % |
5.2% |
8.4% |
|
Equity Ratio |
37.1% |
33.7% |
|
|
||
|
Revenue Growth Rate % |
8.5% |
6.3% |
|
Net Income Growth Rate % |
3.9% |
8.1% |
|
|
||
|
Revenue per Employee |
$6.4M |
$1.6M |
Notes:
-
Because cash amounts can vary dramatically from company to company based on a company’s overall “size,” we’ve presented the numbers as a percentage of sales or revenue: the cash metric divided by total revenue or sales and then multiplied by 100.
-
S&P 500 averages are calculated based on 3 years of annual reports as of July 2024, rounded. However, because certain financial industries, like asset management companies and diversified banks, hold large amounts of cash, they have been removed from the cash calculations.
-
Most industry or sector averages are also calculated based on 3 years of annual reports from S&P 500 companies. However, certain companies or subsectors in the S&P sometimes skew the data far from what is typical for an industry, so we have occasionally removed some companies or subsectors or changed periods in our calculations to provide a more accurate set of comparison data.
- Profitability and LTV Over Raw Growth: The era of growth at all costs is over. Insurers are intentionally shedding unprofitable members and exiting certain geographies to protect their bottom lines. Humana has explicitly shifted its strategy away from "loss leader plans," focusing instead on maximizing customer lifetime value (LTV) and retaining high-quality membership. Commercial growth is similarly measured, with companies like Elevance and UnitedHealth prioritizing margin integrity over raw volume.
- Massive AI and Automation Initiatives: Artificial intelligence is being aggressively deployed to counter rising administrative and medical costs. UnitedHealth Group anticipates nearly $1 billion in AI-enabled operating cost reductions in 2026 alone, using it to handle over 80% of member calls and streamline advocacy. Elevance is also making targeted investments to embed AI-enabled capabilities that simplify the member experience and speed up prior authorizations.
- Hyper-Focus on Specific High-Cost Trends: Rather than fighting general medical inflation, insurers are targeting specific spikes in utilization. Centene noted that behavioral health is driving roughly 50% of their excess medical trend, with home health and high-cost specialty drugs acting as secondary pressure points. Solutions that can effectively manage complex populations or utilize advanced algorithms to detect fraud, waste, and abuse in these areas are highly attractive.
- Pharmacy Benefit Transformation: The pharmacy benefit manager (PBM) space is undergoing a massive structural shift. Cigna and UnitedHealth are heavily promoting new, transparent, "rebate-free" pricing models that pass savings directly to clients and consumers. Furthermore, insurers are heavily leaning into the adoption of lower-cost biosimilars to generate billions in savings over the next few years.
What are the world’s largest energy producers telling Wall Street right now? We analyzed the 2026 strategic outlooks for the top integrated oil and gas players to identify the mission-critical priorities shaping their capital allocation.
1. Advantaged Barrels and Capital Discipline:
The mandate has shifted from "maximum volume" to "lowest cost per barrel." Energy giants are aggressively high-grading their portfolios, offloading high-cost legacy assets to double down on advantaged regions—basins with the lowest extraction costs and carbon intensity. The goal is a rebalanced portfolio that remains profitable even if oil prices dip into the $50 range, ensuring dividend stability regardless of market volatility.
2. Scaling Low-Carbon Solutions as a Business Unit:
Decarbonization is moving from a compliance cost to a standalone revenue stream. Major players are spinning up massive divisions dedicated to Carbon Capture and Storage (CCS), Hydrogen, and Lithium extraction. They are signing long-term "carbon-as-a-service" contracts with heavy-industry customers (such as cement and steel) to help them meet emissions targets, essentially turning their subsurface expertise into a new environmental utility.
3. The Power Generation Pivot for Data Centers:
As AI drives an unprecedented surge in electricity demand, oil and gas firms are positioning themselves as "Total Energy" providers. They are increasingly investing in gas-fired power generation paired with carbon capture to provide the 24/7 baseload power that hyperscale data centers require. By moving further down the value chain—from extracting the molecule to selling the electron—they are capturing higher margins and long-term tech-sector contracts.
4. Digital Twins and Autonomous Exploration:
In 2026, the industry's technology budget is focused on one goal: getting oil out of the ground faster. To do this, companies are creating "Digital Twins"—virtual, 3D replicas of oil fields and offshore platforms—so they can test and simulate the entire drilling process on a computer before they ever touch the real earth. By using self-operating sensors and underwater robots to inspect equipment, companies expect to cut their exploration costs and equipment breakdowns by 20% to 30%. Essentially, they are using these digital tools as a shield to keep their profits high, even as the general cost of doing business rises.
The Scenario:
An AI software vendor was pitching an automated drilling-data platform to a VP of Operations at a major exploration firm, but the VP argued that their veteran engineering team already had "best-in-class" manual processes for analyzing well logs.
The Strategy:
The salesperson switched their focus from arguing process to Revenue per Employee (RPE) by pointing out that while company output was stable, their technical headcount was aging and growing faster than their production—dropping their RPE below the $1.8M industry benchmark for top-tier operators.
The Pivot:
"Your business model relies on high-value human expertise, but right now, your top engineers are spending 40% of their time on manual data cleanup. This is a drag on your Revenue per Headcount. We aren't here to replace your engineers; we are here to unburden them from 'low-value' data tasks so they can manage twice as many wells. By automating the data synthesis, we can push your RPE back above the benchmark, allowing your current team to support your 2027 growth targets without you having to fight for scarce new talent in a tight labor market."
The Result:
The VP stopped seeing a software expense and started seeing a "Human Capital Multiplier." The deal closed because it solved the strategic problem of maintaining production with a shrinking pool of senior experts.
The Scenario:
A chemicals representative was pitching a new, higher-priced enhanced recovery fluid to a Procurement Director. The Director was under strict orders to cut lifting costs (the cost to pull oil out of the ground) and wanted to stick with the cheapest commodity chemicals available.
The Strategy:
The salesperson ignored the cost per gallon and focused on the 3.5% Net Profit Margin. They showed that for every barrel of oil, the firm was accidentally pumping seven barrels of useless water, which cost them millions in disposal fees and energy.
The Pivot:
"If we look only at the price of the fluid, I’m the more expensive option. But look at your Margin Leakage. Right now, your cheap chemicals are letting too much water through, meaning 70% of your energy is going toward pumping and treating waste. Our high-performance fluid reduces that water intake by 15%. Even though the fluid costs more upfront, it lowers your total lifting cost by $2 per barrel. That is a Margin Recovery play that adds $12M to your bottom line this year—something a cheaper chemical could never do."
The Result:
The Procurement Director realized that the expensive fluid was actually a "Cost Reduction Tool." They greenlit the switch because it turned a chemical purchase into a strategy for protecting the facility's overall profitability.
- Profitability and LTV Over Raw Growth: The era of growth at all costs is over. Insurers are intentionally shedding unprofitable members and exiting certain geographies to protect their bottom lines. Humana has explicitly shifted its strategy away from "loss leader plans," focusing instead on maximizing customer lifetime value (LTV) and retaining high-quality membership. Commercial growth is similarly measured, with companies like Elevance and UnitedHealth prioritizing margin integrity over raw volume.
- Massive AI and Automation Initiatives: Artificial intelligence is being aggressively deployed to counter rising administrative and medical costs. UnitedHealth Group anticipates nearly $1 billion in AI-enabled operating cost reductions in 2026 alone, using it to handle over 80% of member calls and streamline advocacy. Elevance is also making targeted investments to embed AI-enabled capabilities that simplify the member experience and speed up prior authorizations.
- Hyper-Focus on Specific High-Cost Trends: Rather than fighting general medical inflation, insurers are targeting specific spikes in utilization. Centene noted that behavioral health is driving roughly 50% of their excess medical trend, with home health and high-cost specialty drugs acting as secondary pressure points. Solutions that can effectively manage complex populations or utilize advanced algorithms to detect fraud, waste, and abuse in these areas are highly attractive.
- Pharmacy Benefit Transformation: The pharmacy benefit manager (PBM) space is undergoing a massive structural shift. Cigna and UnitedHealth are heavily promoting new, transparent, "rebate-free" pricing models that pass savings directly to clients and consumers. Furthermore, insurers are heavily leaning into the adoption of lower-cost biosimilars to generate billions in savings over the next few years.